337 related articles for article (PubMed ID: 27763717)
1. Additive effects of the Rho kinase inhibitor Y-27632 and vardenafil on relaxation of the corpus cavernosum tissue of patients with erectile dysfunction and clinical phosphodiesterase type 5 inhibitor failure.
Uvin P; Albersen M; Bollen I; Falter M; Weyne E; Linsen L; Tinel H; Sandner P; Bivalacqua TJ; De Ridder DJ; Van der Aa F; Brône B; Van Renterghem K
BJU Int; 2017 Feb; 119(2):325-332. PubMed ID: 27763717
[TBL] [Abstract][Full Text] [Related]
2. Synergistic effects of BAY 60-4552 and vardenafil on relaxation of corpus cavernosum tissue of patients with erectile dysfunction and clinical phosphodiesterase type 5 inhibitor failure.
Albersen M; Linsen L; Tinel H; Sandner P; Van Renterghem K
J Sex Med; 2013 May; 10(5):1268-77. PubMed ID: 23421435
[TBL] [Abstract][Full Text] [Related]
3. Mirabegron causes relaxation of human and rat corpus cavernosum: could it be a potential therapy for erectile dysfunction?
Gur S; Peak T; Yafi FA; Kadowitz PJ; Sikka SC; Hellstrom WJ
BJU Int; 2016 Sep; 118(3):464-74. PubMed ID: 27124860
[TBL] [Abstract][Full Text] [Related]
4. Effect of doxazosin with and without rho-kinase inhibitor on human corpus cavernosum smooth muscle in the presence of bladder outlet obstruction.
Demir O; Murat N; Aslan G; Gidener S; Esen AA
J Urol; 2006 Jun; 175(6):2345-9. PubMed ID: 16697871
[TBL] [Abstract][Full Text] [Related]
5. Optimizing nitric oxide production by time dependent L-arginine administration in isolated human corpus cavernosum.
Gur S; Kadowitz PJ; Trost L; Hellstrom WJ
J Urol; 2007 Oct; 178(4 Pt 1):1543-8. PubMed ID: 17707054
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Rho-kinase improves erectile function, increases nitric oxide signaling and decreases penile apoptosis in a rat model of cavernous nerve injury.
Hannan JL; Albersen M; Kutlu O; Gratzke C; Stief CG; Burnett AL; Lysiak JJ; Hedlund P; Bivalacqua TJ
J Urol; 2013 Mar; 189(3):1155-61. PubMed ID: 23021998
[TBL] [Abstract][Full Text] [Related]
7. Testosterone regulates RhoA/Rho-kinase signaling in two distinct animal models of chemical diabetes.
Vignozzi L; Morelli A; Filippi S; Ambrosini S; Mancina R; Luconi M; Mungai S; Vannelli GB; Zhang XH; Forti G; Maggi M
J Sex Med; 2007 May; 4(3):620-632. PubMed ID: 17498101
[TBL] [Abstract][Full Text] [Related]
8. Light-controlled relaxation of the rat penile corpus cavernosum using NOBL-1, a novel nitric oxide releaser.
Hotta Y; Ieda N; Fukamoto A; Kataoka T; Kawade Y; Maeda Y; Nakagawa H; Kimura K
Investig Clin Urol; 2016 May; 57(3):215-20. PubMed ID: 27195321
[TBL] [Abstract][Full Text] [Related]
9. Effects of the Rho-kinase inhibitors, Y-27632 and fasudil, on the corpus cavernosum from diabetic mice.
Büyükafşar K; Un I
Eur J Pharmacol; 2003 Jul; 472(3):235-8. PubMed ID: 12871759
[TBL] [Abstract][Full Text] [Related]
10. RhoA/Rho-kinase suppresses endothelial nitric oxide synthase in the penis: a mechanism for diabetes-associated erectile dysfunction.
Bivalacqua TJ; Champion HC; Usta MF; Cellek S; Chitaley K; Webb RC; Lewis RL; Mills TM; Hellstrom WJ; Kadowitz PJ
Proc Natl Acad Sci U S A; 2004 Jun; 101(24):9121-6. PubMed ID: 15184671
[TBL] [Abstract][Full Text] [Related]
11. Combination of BAY 60-4552 and vardenafil exerts proerectile facilitator effects in rats with cavernous nerve injury: a proof of concept study for the treatment of phosphodiesterase type 5 inhibitor failure.
Oudot A; Behr-Roussel D; Poirier S; Sandner P; Bernabé J; Alexandre L; Giuliano F
Eur Urol; 2011 Nov; 60(5):1020-6. PubMed ID: 21839578
[TBL] [Abstract][Full Text] [Related]
12. Effects of chronic vardenafil treatment persist after end of treatment in rats with acute arteriogenic erectile dysfunction.
Hotta Y; Ohno R; Kataoka T; Mikumo M; Takahata Y; Ohno M; Maeda Y; Kimura K
J Sex Med; 2012 Jul; 9(7):1782-8. PubMed ID: 22548870
[TBL] [Abstract][Full Text] [Related]
13. STIM/Orai Inhibition as a Strategy for Alleviating Diabetic Erectile Dysfunction Through Modulation of Rat and Human Penile Tissue Contractility and in vivo Potentiation of Erectile Responses.
Sevilleja-Ortiz A; El Assar M; García-Gómez B; La Fuente JM; Alonso-Isa M; Romero-Otero J; Martínez-Salamanca JI; Fernández A; Rodríguez-Mañas L; Angulo J
J Sex Med; 2022 Dec; 19(12):1733-1749. PubMed ID: 36195535
[TBL] [Abstract][Full Text] [Related]
14. Vardenafil modulates bladder contractility through cGMP-mediated inhibition of RhoA/Rho kinase signaling pathway in spontaneously hypertensive rats.
Morelli A; Filippi S; Sandner P; Fibbi B; Chavalmane AK; Silvestrini E; Sarchielli E; Vignozzi L; Gacci M; Carini M; Vannelli GB; Maggi M
J Sex Med; 2009 Jun; 6(6):1594-1608. PubMed ID: 19473460
[TBL] [Abstract][Full Text] [Related]
15. Improved erectile function after Rho-kinase inhibition in a rat castrate model of erectile dysfunction.
Wingard CJ; Johnson JA; Holmes A; Prikosh A
Am J Physiol Regul Integr Comp Physiol; 2003 Jun; 284(6):R1572-9. PubMed ID: 12573976
[TBL] [Abstract][Full Text] [Related]
16. Modulation of Ca2+ sensitivity regulates contractility of rabbit corpus cavernosum smooth muscle.
Takahashi R; Nishimura J; Hirano K; Naito S; Kanaide H
J Urol; 2003 Jun; 169(6):2412-6. PubMed ID: 12771808
[TBL] [Abstract][Full Text] [Related]
17. Hydroxyfasudil ameliorates penile dysfunction in the male spontaneously hypertensive rat.
Saito M; Ohmasa F; Dimitriadis F; Tsounapi P; Sejima T; Shimizu S; Kinoshita Y; Satoh K
Pharmacol Res; 2012 Oct; 66(4):325-31. PubMed ID: 22750666
[TBL] [Abstract][Full Text] [Related]
18. Y-27632, an inhibitor of Rho-kinase, antagonizes noradrenergic contractions in the rabbit and human penile corpus cavernosum.
Rees RW; Ralph DJ; Royle M; Moncada S; Cellek S
Br J Pharmacol; 2001 Jun; 133(4):455-8. PubMed ID: 11399661
[TBL] [Abstract][Full Text] [Related]
19. Diabetes exacerbates the functional deficiency of NO/cGMP pathway associated with erectile dysfunction in human corpus cavernosum and penile arteries.
Angulo J; González-Corrochano R; Cuevas P; Fernández A; La Fuente JM; Rolo F; Allona A; Sáenz de Tejada I
J Sex Med; 2010 Feb; 7(2 Pt 1):758-68. PubMed ID: 19912487
[TBL] [Abstract][Full Text] [Related]
20. Change of erectile function and responsiveness to phosphodiesterase type 5 inhibitors at different stages of streptozotocin-induced diabetes in rats.
Cho SY; Park K; Paick JS; Kim SW
J Sex Med; 2011 May; 8(5):1352-61. PubMed ID: 21054802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
